SONOMA PHARMACEUTICALS
Sonoma Pharmaceuticals is a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 33 countries. The company’s products, over 100 SKUs commercialized worldwide, are used to treat patients in advanced wound management, dermatology, women’s health and animal health; addressing the unmet medical needs of these markets—while raising the standard of patient care and lowering overall healthcare costs.
SONOMA PHARMACEUTICALS
Industry:
Health Care
Founded:
1999-01-01
Address:
Petaluma, California, United States
Country:
United States
Website Url:
http://www.sonomapharma.com
Total Employee:
51+
Status:
Active
Contact:
7072830551
Email Addresses:
[email protected]
Total Funding:
76.2 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content Amazon IPv6 Google Apps For Business GoDaddy DNS Google Sectigo SSL Ruby On Rails Token AWS Global Accelerator
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Biofrontera
Biofrontera is a biopharmaceutical company specializing in treating dermatological conditions and diseases.
Innovus Pharmaceuticals
Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Alexandria Venture Investments
Alexandria Venture Investments investment in Post-IPO Equity - Sonoma Pharmaceuticals
Lyell Immunopharma
Lyell Immunopharma investment in Post-IPO Equity - Sonoma Pharmaceuticals
JDRF T1D Fund
JDRF T1D Fund investment in Post-IPO Equity - Sonoma Pharmaceuticals
Octagon Capital Partners
Octagon Capital Partners investment in Post-IPO Equity - Sonoma Pharmaceuticals
ARCH Venture Partners
ARCH Venture Partners investment in Post-IPO Equity - Sonoma Pharmaceuticals
Lifeforce Capital
Lifeforce Capital investment in Post-IPO Equity - Sonoma Pharmaceuticals
8VC
8VC investment in Post-IPO Equity - Sonoma Pharmaceuticals
Lilly Asia Ventures
Lilly Asia Ventures investment in Post-IPO Equity - Sonoma Pharmaceuticals
Montreux Equity Partners
Montreux Equity Partners investment in Post-IPO Equity - Sonoma Pharmaceuticals
Official Site Inspections
http://www.sonomapharma.com Semrush global rank: 4.78 M Semrush visits lastest month: 1.92 K
- Host name: aa1a08f2413674d23.awsglobalaccelerator.com
- IP address: 99.83.157.227
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Sonoma Pharmaceuticals"
Company Information :: Sonoma Pharmaceuticals, Inc. (SNOA)
[email protected]. Company Contact Sonoma Pharmaceuticals, Inc. 5445 Conestoga Court Suite 150 Boulder, CO 80301 T: 800-759-9305 [email protected] ...See details»
Investor Relations :: Sonoma Pharmaceuticals, Inc.
[email protected]. Investor Relations. T: 470-938-1011 [email protected]. Transfer Agent. Computershare 462 South 4th Street Suite 1600 Louisville, KY 40202See details»
Our Leadership Team - Sonoma Pharmaceuticals
Executive Team Amy Trombly is our Chief Executive Officer and also serves on our Board of Directors. She counseled public companies for two decades in corporate and securities law …See details»
Sonoma Pharmaceuticals, Inc. (SNOA) - Yahoo Finance
See the company profile for Sonoma Pharmaceuticals, Inc. (SNOA) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Our mission and vision - Sonoma Pharmaceuticals
A Relentless Passion for Healing We are Sonoma. We change lives for the better. And by changing lives for the better, we better ourselves. Changing lives for the better is more than a …See details»
Sonoma Pharmaceuticals - LinkedIn
Sonoma offers safe early-intervention solutions that provide fast relief and are free from side effects and other limitations. Sonoma Pharmaceuticals is a global healthcare leader dedicated to ...See details»
Sonoma Pharmaceuticals Announces Expanded Partnership with …
Oct 22, 2024 The company's principal office is in Boulder, Colorado, with manufacturing operations in Guadalajara, Mexico. European marketing and sales are headquartered in …See details»
Company Description - Stock Analysis
Jan 25, 2007 5445 Conestoga Court, Suite 150 Boulder, Colorado 80301 United StatesSee details»
Sonoma Pharmaceuticals - Overview, News & Similar companies
Jan 9, 2024 www.sonomapharma.com. Revenue $12.3 Million. Stock Symbol SNOA. Industry Pharmaceuticals Healthcare . Recent News & Media. Sonoma Pharmaceuticals Third Quarter …See details»
Sonoma Pharmaceuticals Company Profile | Management and
[email protected]: Sonoma Pharmaceuticals Top Competitors. Company Employees Revenue Top technologies; Elorac Inc. 17: $4.4 M: Innocoll Inc. n/a: $4.4 M: Connetics. n/a: …See details»
About Sonoma Pharmaceuticals
Nov 7, 2023 Sonoma Pharmaceuticals is global-health care leader with over 20 years of experience producing stabilized HOCL for a wide range of conditions. We are empathy-led …See details»
Our Products - Sonoma Pharmaceuticals
Explore Our Line of Microcyn Technology Products Rx Products Our Rx products are backed by the first revolutionary stable patented HOCI formulation in a bottle, Microcyn Technology. …See details»
Sonoma Pharmaceuticals Company Overview, Contact Details
Partnership Expansion Strategy Sonoma Pharmaceuticals has been actively expanding its partnership network with companies like EMC Pharma, Medline Industries, and NovaBay …See details»
Sonoma Pharmaceuticals, Inc. (SNOA) - Stock Analysis
5 days ago Website https://sonomapharma.com. Full Company Profile. Financial Performance. In 2023, Sonoma Pharmaceuticals's revenue was $12.74 million, a decrease of -4.05% …See details»
Sonoma Pharmaceuticals Announces Management Changes
More information can be found at www.sonomapharma.com. Forward-Looking Statements Except for historical information herein, matters set forth in this press release are forward-looking …See details»
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 …
Feb 8, 2024 Results for the Quarter Ended December 31, 2023. Revenues for the quarter ended December 31, 2023 of $3.2 million increased 7% compared to the same period last year. U.S. …See details»
Organization: Sonoma Pharmaceuticals - Cbonds.com
Sonoma Pharmaceuticals. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»
Sonoma Pharmaceuticals - Overview, News & Competitors
View Sonoma Pharmaceuticals (www.sonomapharma.eu) location in United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Customer Login
Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced …See details»